Xiaoxu Jiang
Director of Finance/CFO at Shanghai NewMed Medical Co., Ltd.
Profile
Xiaoxu Jiang is currently the Chief Financial Officer & Joint Secretary at Shanghai NewMed Medical Co., Ltd.
Prior to this, he held the position of Managing Director-Consumer & Healthcare Sector at CCB International Capital Ltd.
from 2017 to 2021.
He also worked as Vice President & Principal at Piper Jaffray Asia Securities Ltd.
from 2010 to 2017 and as an Associate at Susquehanna International Group LLP (China) from 2008 to 2009.
Additionally, Mr. Jiang briefly served as the Chief Financial Officer at Fosun Kite Biotechnology Co., Ltd.
in 2021 and as the Managing Partner at Shanghai Yijie Information Consulting Co., Ltd.
in 2017.
He obtained a graduate degree from the University of Iowa in 1999 and completed his undergraduate and graduate degrees at West China University of Medical Sciences in 1995 and 1996 respectively.
Mr. Jiang also holds an MBA from Columbia Business School, which he earned in 2005.
Xiaoxu Jiang active positions
Companies | Position | Start |
---|---|---|
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | Director of Finance/CFO | 2021-04-30 |
Former positions of Xiaoxu Jiang
Companies | Position | End |
---|---|---|
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Director of Finance/CFO | 2021-04-30 |
CCB International Capital Ltd.
CCB International Capital Ltd. Investment Banks/BrokersFinance CCB International Capital Ltd. provides financial advisory and brokerage services. The company is based in Hong Kong, Hong Kong. The Chinese company is ultimately controlled by the Government of China. | Corporate Officer/Principal | 2020-12-31 |
Shanghai Yijie Information Consulting Co., Ltd. | Chief Executive Officer | 2017-10-31 |
Piper Jaffray Asia Securities Ltd. | Corporate Officer/Principal | 2017-01-31 |
Susquehanna International Group LLP (China) | Corporate Officer/Principal | 2009-09-30 |
Training of Xiaoxu Jiang
West China University of Medical Sciences | Graduate Degree |
University of Iowa | Graduate Degree |
Columbia Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 6 |
---|---|
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | Health Technology |
Susquehanna International Group LLP (China) | |
Piper Jaffray Asia Securities Ltd. | Finance |
Shanghai Yijie Information Consulting Co., Ltd. | |
CCB International Capital Ltd.
CCB International Capital Ltd. Investment Banks/BrokersFinance CCB International Capital Ltd. provides financial advisory and brokerage services. The company is based in Hong Kong, Hong Kong. The Chinese company is ultimately controlled by the Government of China. | Finance |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Health Technology |
- Stock Market
- Insiders
- Xiaoxu Jiang